Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia

Br J Haematol. 2019 Apr;185(2):360-363. doi: 10.1111/bjh.15507. Epub 2018 Jul 20.

¹ Department of Paediatric Haematology/Oncology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
² University of Tor Vergata, Rome, Italy.
³ Paediatric Haematology/Oncology, Policlinico di Bari, Bari, Italy.
⁴ Department of Women's and Children's Health, University of Padova, Padua, Italy.
⁵ Clinical Experimental Haematology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
⁶ Paediatric Haematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁷ Department of Paediatric Haemato-Oncology, Santobono-Pausilipon Hospital, Naples, Italy.
⁸ Department of Cellular Biotechnologies and Haematology, La Sapienza University, Rome, Italy.
⁹ Department of Paediatric Sciences, University of Pavia, Pavia, Italy.

No abstract available

Keywords: acute promyelocytic leukaemia; all-trans retinoic acid; arsenic trioxide; childhood leukaemia.

Publication types